Background: Dermoscopy of granuloma annulare has been investigated by several studies, but none of them took into account the variability of dermoscopic findings according to clinical characteristics and/or histological subtype. Objective: To describe the dermoscopic features of classic granuloma annulare and seek possible dermoscopic clues related to specific clinical findings/histological subpatterns. Methods: A representative dermoscopic image of a target lesion (the most active lesion underwent histological examination) was retrospectively assessed for the presence of specific morphological findings, correlating them with clinical variables, i.e. disease duration and extension (localized or generalized) and clinical aspect (annular or non-annular) and localization (trunk or extremities) of the biopsied lesion, and with histological subtype. Results: A total of 25 lesions from 25 subjects were analysed; an “interstitial” histological variant was detected in 11 cases, while a “palisading granuloma” histological pattern was found in 14 instances. The most common dermoscopic findings included blurry vessels having variable appearance (dotted, linear-irregular, and branching) over a more or less evident pinkish-reddish background, followed by whitish and/or yellowish-orange areas. Additional findings were rosettes, crystalline structures, and whitish scaling. No difference (p > 0.05) in the frequency of dermoscopic features according to clinical findings was found, while we observed a strict association (p < 0.001) between the presence of yellowish-orange structureless areas on dermoscopy and “palisading granuloma” histology. Conclusion: The dermoscopic aspect of granuloma annulare is independent from clinical features but varies according to histological subtype, with the detection of yellowish-orange colour being indicative of the “palisading granuloma” variant.

Keywords:
Histology, Inflammoscopy, Dermoscopy, Granuloma annulare, Granulomatous skin diseases
1.
Keimig EL: Granuloma annulare. Dermatol Clin 2015;33:315-329.
2.
Piette EW, Rosenbach M: Granuloma annulare: clinical and histologic variants, epidemiology, and genetics. J Am Acad Dermatol 2016;75:457-465.
3.
Errichetti E, Stinco G: The practical usefulness of dermoscopy in general dermatology. G Ital Dermatol Venereol 2015;150:533-546.
4.
Lallas A, Giacomel J, Argenziano G, et al: Dermoscopy in general dermatology: practical tips for the clinician. Br J Dermatol 2014;170:514-526.
5.
Lallas A, Zalaudek I, Argenziano G, et al: Dermoscopy in general dermatology. Dermatol Clin 2013;31:679-694.
6.
Zalaudek I, Argenziano G, Di Stefani A, et al: Dermoscopy in general dermatology. Dermatology 2006;212:7-18.
7.
Errichetti E, Stinco G: Dermoscopy in general dermatology: a practical overview. Dermatol Ther (Heidelb) DOI: 10.1007/s13555-016-0141-6.
8.
Errichetti E, Lacarrubba F, Micali G, Piccirillo A, Stinco G: Differentiation of pityriasis lichenoides chronica from guttate psoriasis by dermoscopy. Clin Exp Dermatol 2015;40:804-806.
9.
Errichetti E, Piccirillo A, Stinco G: Dermoscopy of prurigo nodularis. J Dermatol 2015;42:632-634.
10.
Errichetti E, Lacarrubba F, Micali G, Stinco G: Dermoscopy of Zoon's plasma cell balanitis. J Eur Acad Dermatol Venereol DOI: 10.1111/jdv.13538.
11.
Errichetti E, Piccirillo A, Stinco G: Dermoscopy as an auxiliary tool in the differentiation of the main types of erythroderma due to dermatological disorders. Int J Dermatol DOI: 10.1111/ijd.13322.
12.
Errichetti E, Piccirillo A, Viola L, Stinco G: Dermoscopy of subacute cutaneous lupus erythematosus. Int J Dermatol DOI: 10.1111/ijd.13331.
13.
Errichetti E, De Francesco V, Pegolo E, Stinco G: Dermoscopy of Grover's disease: variability according to histological subtype. J Dermatol 2016;43:937-939.
14.
Errichetti E, Stinco G: Dermoscopy as a supportive instrument in the differentiation of the main types of acquired keratoderma due to dermatological disorders. J Eur Acad Dermatol Venereol DOI: 10.1111/jdv.13566.
15.
Errichetti E, Stinco G, Lacarrubba F, Micali G: Dermoscopy of Darier's disease. J Eur Acad Dermatol Venereol 2016;30:1392-1394.
16.
Errichetti E, Stinco G: Dermoscopy in differential diagnosis of palmar psoriasis and chronic hand eczema. J Dermatol 2016;43:423-425.
17.
Lallas A, Kyrgidis A, Tzellos TG, et al: Accuracy of dermoscopic criteria for the diagnosis of psoriasis, dermatitis, lichen planus and pityriasis rosea. Br J Dermatol 2012;166:1198-1205.
18.
Lallas A, Argenziano G, Apalla Z, et al: Dermoscopic patterns of common facial inflammatory skin diseases. J Eur Acad Dermatol Venereol 2014;28:609-614.
19.
Lallas A, Apalla Z, Lefaki I, et al: Dermoscopy of discoid lupus erythematosus. Br J Dermatol 2013;168:284-288.
20.
Lallas A, Zaballos P, Zalaudek I, et al: Dermoscopic patterns of granuloma annulare and necrobiosis lipoidica. Clin Exp Dermatol 2013;38:425-427.
21.
Pellicano R, Caldarola G, Filabozzi P, Zalaudek I: Dermoscopy of necrobiosis lipoidica and granuloma annulare. Dermatology 2013;226:319-323.
22.
Navarrete-Dechent C, Puerto CD, Bajaj S, Marghoob AA, González S, Jaque A: Dermoscopy of elastosis perforans serpiginosa: a useful tool to distinguish it from granuloma annulare. J Am Acad Dermatol 2015;73:e7-e9.
23.
Xu P, Tan C: Crystalline leaf venation: a dermoscopic clue for diagnosing granuloma annulare. Eur J Dermatol 2015;25:356-357.
24.
Ramadan S, Hossam D, Saleh MA: Dermoscopy could be useful in differentiating sarcoidosis from necrobiotic granulomas even after treatment with systemic steroids. Dermatol Pract Concept 2016;6:17-22.
25.
Calonje E, Brenn T, Lazar A, McKee PH: Granulomatous, necrobiotic and perforating dermatoses; in Calonje E, Brenn T, Lazar A, McKee PH (eds): McKee's Pathology of the Skin, ed 4. Edinburgh, Elsevier Saunders, 2012, pp 288-294.
26.
Marghoob AA, Cowell L, Kopf AW, Scope A: Observation of chrysalis structures with polarized dermoscopy. Arch Dermatol 2009;145:618.
27.
Marques-da-Costa J, Campos-do-Carmo G, Ormiga P, Ishida CE, Cuzzi T, Ramos-e-Silva M: Rosette sign in dermatoscopy: a polarized finding. Skinmed 2011;9:392.
28.
Bombonato C, Argenziano G, Lallas A, Moscarella E, Ragazzi M, Longo C: Orange color: a dermoscopic clue for the diagnosis of granulomatous skin diseases. J Am Acad Dermatol 2015;72:S60-S63.
29.
Jackson SM, Nesbitt LT: The diagnosis; in Jackson SM, Nesbitt LT (eds): Differential Diagnosis for the Dermatologist, ed 2. New York, Springer, 2012, pp 702-705.
30.
Güngör Ş, Topal IO, Göncü EK: Dermoscopic patterns in active and regressive lichen planus and lichen planus variants: a morphological study. Dermatol Pract Concept 2015;5:45-53.
31.
Ramírez-Bellver JL, Bernárdez C, Macías E, et al: Dermoscopy and direct immunofluorescence findings of elastosis perforans serpiginosa. Clin Exp Dermatol 2016;41:667-670.
32.
Rubegni P, Tognetti L, Mandato F, Fimiani M: Nonpigmented skin lesions: Xanthomatous lesions; in Micali G, Lacarrubba F (eds): Dermatoscopy in Clinical Practice beyond Pigmented Lesions, ed 2. Boca Raton, CRC Press, 2016, pp 131-135.
33.
Dabski K, Winkelmann RK: Generalized granuloma annulare: histopathology and immunopathology. Systematic review of 100 cases and comparison with localized granuloma annulare. J Am Acad Dermatol 1989;20:28-39.
34.
Dicken CH, Carrington SG, Winkelmann RK: Generalized granuloma annulare. Arch Dermatol 1969;99:556-563.
© 2017 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.